BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20472556)

  • 1. Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.
    Shinohara M; Sato N; Kurinami H; Takeuchi D; Takeda S; Shimamura M; Yamashita T; Uchiyama Y; Rakugi H; Morishita R
    J Biol Chem; 2010 Jul; 285(29):22091-102. PubMed ID: 20472556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells.
    Zandl-Lang M; Fanaee-Danesh E; Sun Y; Albrecher NM; Gali CC; Čančar I; Kober A; Tam-Amersdorfer C; Stracke A; Storck SM; Saeed A; Stefulj J; Pietrzik CU; Wilson MR; Björkhem I; Panzenboeck U
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):40-60. PubMed ID: 28941799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effects of statins on Aβ metabolism: upregulation of the degradation of APP-CTF and Aβ clearance.
    Sato N; Shinohara M; Rakugi H; Morishita R
    Neurodegener Dis; 2012; 10(1-4):305-8. PubMed ID: 22301944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.
    Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.
    Maulik M; Peake K; Chung J; Wang Y; Vance JE; Kar S
    Hum Mol Genet; 2015 Dec; 24(24):7132-50. PubMed ID: 26433932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroautophagy is not directly involved in the metabolism of amyloid precursor protein.
    Boland B; Smith DA; Mooney D; Jung SS; Walsh DM; Platt FM
    J Biol Chem; 2010 Nov; 285(48):37415-26. PubMed ID: 20864542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
    Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
    Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
    P X; Zz L; Gg J; Lp W; Cm B; Yl W; Chen MF; W L
    Neurochem Int; 2022 Nov; 160():105417. PubMed ID: 36067928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
    Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
    J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
    Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
    Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced brain amyloid-β clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease.
    Qosa H; Abuznait AH; Hill RA; Kaddoumi A
    J Alzheimers Dis; 2012; 31(1):151-65. PubMed ID: 22504320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
    Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
    Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
    Alemi M; Silva SC; Santana I; Cardoso I
    CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional role of lipoprotein receptors in Alzheimer's disease.
    Jaeger S; Pietrzik CU
    Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.
    Mohamed LA; Zhu H; Mousa YM; Wang E; Qiu WQ; Kaddoumi A
    J Alzheimers Dis; 2017; 56(3):1087-1099. PubMed ID: 28059785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
    Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
    Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
    Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
    J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM.
    Storck SE; Hartz AMS; Bernard J; Wolf A; Kachlmeier A; Mahringer A; Weggen S; Pahnke J; Pietrzik CU
    Brain Behav Immun; 2018 Oct; 73():21-33. PubMed ID: 30041013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal clearance of amyloid-β by endocytic receptor LRP1.
    Kanekiyo T; Cirrito JR; Liu CC; Shinohara M; Li J; Schuler DR; Shinohara M; Holtzman DM; Bu G
    J Neurosci; 2013 Dec; 33(49):19276-83. PubMed ID: 24305823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.